MAGY Only Makes Sense If You Already Own The Underlying
seekingalpha.com
Want to monitor OVID?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor OVIDovid therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. ovid’s drug candidate, ov101, is currently in development for the treatment of symptoms of angelman syndrome and fragile x syndrome. ovid is also developing ov935 in collaboration with takeda pharmaceutical company limited for the treatment of rare epileptic encephalopathies.